(Q47928079)

English

Immunogenic properties of a recombinant fusion protein containing the C-terminal 19 kDa of Plasmodium falciparum merozoite surface protein-1 and the innate immunity agonist FliC flagellin of Salmonella typhimurium.

scientific article published on 17 February 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20170765%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Immunogenic properties of a recombinant fusion protein containing the C-terminal 19 kDa of Plasmodium falciparum merozoite surface protein-1 and the innate immunity agonist FliC flagellin of Salmonella typhimurium (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20170765%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Plasmodium falciparum

1 reference

based on heuristic

inferred from title

Salmonella Typhimurium

1 reference

based on heuristic

inferred from title

Daniel Youssef Bargieri

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20170765%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Stefanie C P Lopes

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20170765%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Luis Carlos de Souza Ferreira

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20170765%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Juliana A Leite

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20170765%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Maria Elisabete Sbrogio-Almeida

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20170765%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Catarina J M Braga

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20170765%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Irene S Soares

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20170765%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Fabio T M Costa

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20170765%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Mauricio M Rodrigues

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20170765%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

language of work or name

0 references

publication date

17 February 2010

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20170765%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

number of pages

9

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20170765%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

28

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20170765%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20170765%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

2818-2826

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20170765%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Antimalarial drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.004

7 January 2021

Recent insights into humoral and cellular immune responses against malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.004

7 January 2021

Immune responses to asexual blood-stages of malaria parasites

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.004

7 January 2021

Immune response to pre-erythrocytic stages of malaria parasites.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.004

7 January 2021

Protective immunity against malaria liver stage after vaccination with live parasites

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.004

7 January 2021

Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.004

7 January 2021

Safety and immunogenicity of RTS,S/AS02D malaria vaccine in infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.004

7 January 2021

The major merozoite surface protein as a malaria vaccine target

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.004

7 January 2021

A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.004

7 January 2021

Functional conservation of the malaria vaccine antigen MSP-119across distantly related Plasmodium species.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.004

7 January 2021

Clonal conditional mutagenesis in malaria parasites

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.004

7 January 2021

MSP-1p42-specific antibodies affect growth and development of intra-erythrocytic parasites of Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.004

7 January 2021

Efficacy of two alternate vaccines based on Plasmodium falciparum merozoite surface protein 1 in an Aotus challenge trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.004

7 January 2021

Protection induced by Plasmodium falciparum MSP1(42) is strain-specific, antigen and adjuvant dependent, and correlates with antibody responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.004

7 January 2021

Immunogenicity and in vivo efficacy of recombinant Plasmodium falciparum merozoite surface protein-1 in Aotus monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.004

7 January 2021

Immunity to recombinant plasmodium falciparum merozoite surface protein 1 (MSP1): protection in Aotus nancymai monkeys strongly correlates with anti-MSP1 antibody titer and in vitro parasite-inhibitory activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.004

7 January 2021

The clinical-grade 42-kilodalton fragment of merozoite surface protein 1 of Plasmodium falciparum strain FVO expressed in Escherichia coli protects Aotus nancymai against challenge with homologous erythrocytic-stage parasites

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.004

7 January 2021

A recombinant vaccine expressed in the milk of transgenic mice protects Aotus monkeys from a lethal challenge with Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.004

7 January 2021

Innate immune recognition

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.004

7 January 2021

Pathogen recognition and innate immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.004

7 January 2021

Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1beta via Ipaf

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.004

7 January 2021

Toll-like receptor 5 recognizes a conserved site on flagellin required for protofilament formation and bacterial motility

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.004

7 January 2021

Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1beta in salmonella-infected macrophages

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.004

7 January 2021

The Nod-like receptor family member Naip5/Birc1e restricts Legionella pneumophila growth independently of caspase-1 activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.004

7 January 2021

The Birc1e cytosolic pattern-recognition receptor contributes to the detection and control of Legionella pneumophila infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.004

7 January 2021

NAIP and Ipaf control Legionella pneumophila replication in human cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.004

7 January 2021

Flagellin-deficient Legionella mutants evade caspase-1- and Naip5-mediated macrophage immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.004

7 January 2021

The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.004

7 January 2021

A West Nile virus recombinant protein vaccine that coactivates innate and adaptive immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.004

7 January 2021

Flagellin fusion proteins as adjuvants or vaccines induce specific immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.004

7 January 2021

Immunogenicity of cholera toxin B epitope inserted in Salmonella flagellin expressed on bacteria and administered as DNA vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.004

7 January 2021

Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.004

7 January 2021

Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.004

7 January 2021

Efficacious recombinant influenza vaccines produced by high yield bacterial expression: a solution to global pandemic and seasonal needs.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.004

7 January 2021

A universal epitope-based influenza vaccine and its efficacy against H5N1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.004

7 January 2021

Flagellin as a good carrier and potent adjuvant for Th1 response: study of mice immune response to the p27 (Rv2108) Mycobacterium tuberculosis antigen.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.004

7 January 2021

Paracoccidioides brasiliensis vaccine formulations based on the gp43-derived P10 sequence and the Salmonella enterica FliC flagellin.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.004

7 January 2021

A bacterial flagellin, Vibrio vulnificus FlaB, has a strong mucosal adjuvant activity to induce protective immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.004

7 January 2021

Cellular mechanisms of the adjuvant activity of the flagellin component FljB of Salmonella enterica Serovar Typhimurium to potentiate mucosal and systemic responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.004

7 January 2021

Flagellin is an effective adjuvant for immunization against lethal respiratory challenge with Yersinia pestis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.004

7 January 2021

Flagellin-F1-V fusion protein is an effective plague vaccine in mice and two species of nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.004

7 January 2021

A fusion protein vaccine containing OprF epitope 8, OprI, and type A and B flagellins promotes enhanced clearance of nonmucoid Pseudomonas aeruginosa.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.004

7 January 2021

New malaria vaccine candidates based on the Plasmodium vivax Merozoite Surface Protein-1 and the TLR-5 agonist Salmonella Typhimurium FliC flagellin.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.004

7 January 2021

Comparison of the immunogenic properties of recombinant proteins representing the Plasmodium vivax vaccine candidate MSP1(19) expressed in distinct bacterial vectors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.004

7 January 2021

The attenuated phenotype of a Salmonella typhimurium flgM mutant is related to expression of FliC flagellin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.004

7 January 2021

Sequestration of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate A, a receptor for maternal malaria: monoclonal antibodies against the native parasite ligand reveal pan-reactive epitopes in placental isolates.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.004

7 January 2021

Human malaria parasites in continuous culture

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.004

7 January 2021

Antibodies against merozoite surface protein (MSP)-1(19) are a major component of the invasion-inhibitory response in individuals immune to malaria.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.004

7 January 2021

Blood stage malaria vaccine eliciting high antigen-specific antibody concentrations confers no protection to young children in Western Kenya

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.004

7 January 2021

Antibodies that inhibit malaria merozoite surface protein-1 processing and erythrocyte invasion are blocked by naturally acquired human antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.004

7 January 2021

The carboxy-terminus of merozoite surface protein 1: structure, specific antibodies and immunity to malaria.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.004

7 January 2021

Comparison of immunogenicity of five MSP1-based malaria vaccine candidate antigens in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.004

7 January 2021

Direct stimulation of tlr5+/+ CD11c+ cells is necessary for the adjuvant activity of flagellin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.004

7 January 2021

The Toll-Like Receptor 5 Stimulus Bacterial Flagellin Induces Maturation and Chemokine Production in Human Dendritic Cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.004

7 January 2021

Induction of adaptive immunity by flagellin does not require robust activation of innate immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.004

7 January 2021

Identification of a novel negative role of flagellin in regulating IL-10 production.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.004

7 January 2021

A recombinant baculovirus 42-kilodalton C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 protects Aotus monkeys against malaria.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.004

7 January 2021

based on heuristic

inferred from DOI database lookup

Intranasal administration of synthetic recombinant peptide-based vaccine protects mice from infection by Schistosoma mansoni.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.004

7 January 2021

based on heuristic

inferred from DOI database lookup

Predominance of CD4 Th1 and CD8 Tc1 cells revealed by characterization of the cellular immune response generated by immunization with a DNA vaccine containing a Trypanosoma cruzi gene.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.004

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47928079&oldid=1796215394"